Average Co-Inventor Count = 4.45
ph-index = 32
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (116 from 2,284 patents)
2. Allergan Sales, Inc. (17 from 228 patents)
3. Other (3 from 831,952 patents)
4. City of Hope National Medical Center (1 from 13 patents)
5. Allergen Sales, Inc. (1 from 4 patents)
6. Allegran, Inc. (1 from 1 patent)
138 patents:
1. 11286234 - Phenyl urea derivatives as N-formyl peptide receptor modulators
2. 11117860 - Phenyl urea derivatives as n-formyl peptide receptor modulators
3. 11046644 - Sulfur derivatives as chemokine receptor modulators
4. 10993931 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
5. 10899780 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
6. 10800744 - Imidazole derivatives as formyl peptide receptor modulators
7. 10799518 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
8. 10434112 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
9. 10301269 - Imidazole derivatives as formyl peptide receptor modulators
10. 10287243 - Sulfur derivatives as chemokine receptor modulators
11. 10208071 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
12. 10172832 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
13. 9974772 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
14. 9926264 - Phenylcarbamate derivatives as formyl peptide receptor modulators
15. 9920013 - 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators